All data are based on the daily closing price as of September 6, 2024
a
Alfresa Holdings
2784.TSE
16.96 USD
-0.15
-0.88%
Overview
Last close
16.96 usd
Market cap
3.17B usd
52 week high
17.73 usd
52 week low
13.17 usd
Target price
16.31 usd
Valuation
P/E
15.3607
Forward P/E
N/A
Price/Sales
0.1575
Price/Book Value
0.9434
Enterprise Value
1.92B usd
EV/Revenue
0.0953
EV/EBITDA
6.1423
Key financials
Revenue TTM
20.19B usd
Gross Profit TTM
1.35B usd
EBITDA TTM
371.72M usd
Earnings per Share
1.11 usd
Dividend
0.42 usd
Total assets
9.14B usd
Net debt
-1.18B usd
About
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related businesses. The company was incorporated in 2003 and is based in Tokyo, Japan.